Related Experiment Videos
Studies on the formation of a unique cellular intermediate (EAC14256) from EAC142 and C56
1Department of Immunology, Center for Adult Diseases, Osaka, Japan.
International Archives of Allergy and Applied Immunology
|January 1, 1988
Summary
Complement component C56 binds to EAC142 forming EAC14256, a crucial step in C3-independent immune hemolysis. This reversible binding is independent of the typical complement cascade activation pathway.
Area of Science:
- Immunology
- Complement System Biology
Background:
- The complement system is a critical part of innate immunity.
- Understanding the early steps of complement activation is vital for immune response research.
Purpose of the Study:
- To investigate the binding reaction between complement component C56 and EAC142.
- To elucidate the mechanism and characteristics of EAC14256 formation.
Main Methods:
- Studied the binding of purified C56 to EAC142 under varying ionic strengths.
- Analyzed the reversibility and decay of the EAC14256 complex.
- Identified the cellular receptor for C56 on EAC142.
Main Results:
- C56 binds to EAC142 independently of C3 and C7, forming EAC14256.
- The formation of EAC14256 is highly dependent on buffer ionic strength.
- The binding is reversible, with C56 eluting spontaneously.
- C2 or C42 on the cell surface serves as the receptor for C56.
- C56 binding to cells is independent of C3-dependent complement activation.
Conclusions:
- The binding of C56 to EAC142 is a key initial step in the formation of the membrane attack complex.
- This process can occur independently of the classical C3-dependent complement cascade.
- Suggests a novel pathway for C3-independent immune hemolysis.